PHAM QUANG X (CEO and Chairman) sold 7.0% of their position (7.40K shares) of CADRENAL THERAPEUTICS, INC. on the open market
Open‑market sale worth $22.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2026ACC: 0001213900-26-074557
DirectorOfficer10% Owner· CEO and Chairman
Since Jan 2023
-7.40K
Net shares
Net seller
$22.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.40K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.40K
Price / share
$3.03
Trade value
$22.42K
% of position
7.0%
6/29/2026
105.99K→98.59K
Total
Net shares
−7.40K
Net value
-$22.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/29/2026 | S · Sale | −7.40K | $3.03 | $22.42K | 7.0% | 105.99K | 98.59K |
| Total | −7.40K | -$22.42K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned200K
Total
200K indirect200K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 200K | Indirect |
| Total | 200K | 200K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported